HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Ji Selected Research

Zj6413

5/2016Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Ji Research Topics

Disease

36Neoplasms (Cancer)
08/2022 - 01/2002
7Hypoxia (Hypoxemia)
01/2016 - 09/2002
6Breast Neoplasms (Breast Cancer)
04/2022 - 01/2016
6Glioblastoma (Glioblastoma Multiforme)
02/2022 - 01/2017
4Weight Loss (Weight Reduction)
01/2022 - 09/2002
3Glioma (Gliomas)
02/2022 - 01/2019
3Neoplasm Metastasis (Metastasis)
02/2022 - 05/2016
3Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 02/2017
3Carcinogenesis
01/2021 - 10/2012
3Prostatic Neoplasms (Prostate Cancer)
12/2020 - 05/2008
3Infections
05/2020 - 10/2014
3Type 2 Diabetes Mellitus (MODY)
11/2017 - 04/2005
2Disease Progression
09/2022 - 03/2015
2Cognitive Dysfunction
06/2022 - 09/2019
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
06/2022 - 07/2015
2Ischemic Stroke
01/2022 - 01/2021
2Body Weight (Weight, Body)
01/2022 - 03/2015
2Inflammation (Inflammations)
12/2021 - 03/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020 - 05/2020
2Psoriasis (Pustulosis Palmaris et Plantaris)
02/2020 - 04/2018
2Adenoma (Adenomas)
05/2019 - 02/2017
2Pain (Aches)
01/2019 - 12/2016
2Triple Negative Breast Neoplasms
12/2018 - 05/2016
2Fibrosis (Cirrhosis)
01/2017 - 12/2013
2Autistic Disorder (Autism)
05/2008 - 09/2006
1Asthenia
09/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
09/2022
1Dyspnea (Shortness of Breath)
09/2022
1Neuromuscular Diseases (Neuromuscular Disease)
09/2022
1Sleep Deprivation
06/2022
1Adenocarcinoma
05/2022
1Peripheral Nervous System Diseases (PNS Diseases)
04/2022
1Hypothyroidism
04/2022
1Brain Neoplasms (Brain Tumor)
02/2022
1Infarction (Infarctions)
01/2022
1Rupture
01/2022
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022
1Stroke (Strokes)
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2021
1Mental Disorders (Mental Disorder)
10/2021
1Major Depressive Disorder (Major Depressive Disorders)
10/2021

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
08/2022 - 05/2012
9Pharmaceutical PreparationsIBA
09/2022 - 09/2015
6Biological ProductsIBA
10/2021 - 01/2016
6Cytotoxins (Cytolysins)IBA
06/2011 - 01/2002
54- (3- (2- nitro- 1- imidazolyl)- propylamino)- 7- chloroquinoline hydrochlorideIBA
06/2011 - 01/2002
4Paclitaxel (Taxol)FDA LinkGeneric
12/2020 - 01/2002
3InflammasomesIBA
06/2022 - 01/2022
3NucleotidesIBA
06/2022 - 01/2022
3Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 05/2016
3MicroRNAs (MicroRNA)IBA
05/2019 - 10/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 12/2012
2Therapeutic UsesIBA
06/2022 - 01/2019
2ProdrugsIBA
06/2022 - 01/2018
2AntibodiesIBA
06/2022 - 10/2014
2CholesterolIBA
04/2022 - 03/2015
2N-dodecyl-L-lysine amideIBA
01/2022 - 11/2021
2GlucocorticoidsIBA
12/2021 - 01/2019
2Antineoplastic Agents (Antineoplastics)IBA
05/2021 - 12/2018
2CateninsIBA
01/2021 - 01/2017
2IronIBA
01/2021 - 01/2021
2Chlorogenic AcidIBA
09/2020 - 01/2017
2Liposomes (Liposome)IBA
09/2020 - 01/2019
2Mannose ReceptorIBA
09/2020 - 01/2019
2EnzymesIBA
01/2020 - 01/2003
2Sphingosine-1-Phosphate ReceptorsIBA
01/2019 - 04/2018
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2018 - 09/2015
2C-Reactive ProteinIBA
12/2016 - 03/2015
2Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2016 - 01/2016
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2016 - 12/2012
2AntigensIBA
01/2016 - 05/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 09/2015
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2011 - 09/2002
2Tirapazamine (SR 4233)IBA
12/2002 - 09/2002
1Oncogene Proteins (Oncogene Protein)IBA
08/2022
1LeptinIBA
06/2022
1Leucine (L-Leucine)FDA Link
06/2022
1Adenosine Triphosphate (ATP)IBA
06/2022
1Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
05/2022
1Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2022
1taxaneIBA
04/2022
1Apolipoprotein E4IBA
04/2022
1Interleukin-17 (Interleukin 17)IBA
02/2022
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
02/2022
1Messenger RNA (mRNA)IBA
01/2022
1LithiumIBA
01/2022
1Coal (Coals)IBA
01/2022
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
12/2021
1SulfonesIBA
11/2021
1Antidepressive Agents (Antidepressants)IBA
10/2021
1nitazoxanide (NTZ)FDA Link
05/2021
1pyrimidineIBA
01/2021

Therapy/Procedure

12Therapeutics
09/2022 - 02/2017
4Immunotherapy
06/2022 - 09/2020
4Drug Therapy (Chemotherapy)
04/2022 - 09/2002
3Oral Administration
02/2022 - 12/2020
3Bariatric Surgery
01/2022 - 01/2021
2Length of Stay
05/2020 - 04/2019
2Radiotherapy
01/2016 - 12/2013
1Thyroidectomy
04/2022